UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 11, 2016
Accession Number:
0001193125-16-583894
Submission Type:
POS AM
CIK:
0000315545
Company Name:
PROVECTUS BIOPHARMACEUTICALS, INC.
File Number:
333-208816